The Online Investor
Biotechnology M&A image Biotechnology M&A » By The Online Investor Staff, updated Mon., Jul. 4, 11:26 AM Recent mergers and acquisitions in the Biotechnology M&A category.

Slide #58. Techne Corporation Bionostics Holdings Limited

Acquirer: Techne Corporation (NASDAQ:TECH)
Acquiree: Bionostics Holdings Limited
Details: Techne Corporation (NASDAQ: TECH) (Techne) announced today that it has finalized its previously announced acquisition of Bionostics Holdings Limited and its operating subsidiary Bionostics, Inc. (Bionostics). Bionostics was acquired for approximately $104 million in cash, subject to adjustments following closing based on the final level of working capital.

Bio-Techne develops, manufactures and sells life science reagents, instruments and services for the research, diagnostics and bioprocessing markets. Co.'s segments include: Protein Sciences, which develops and manufactures biological reagents used in life science research, diagnostics and cell and gene therapy; and Diagnostics and Genomics, which develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications.

TECH SEC Filing Email Alerts Service


Open the TECH Page at The Online Investor »

Company Name: 
Bio-Techne Corp
Stock buyback: 
TECH buyback
Website: 
www.bio-techne.com
Sector: 
Biotechnology
Number of ETFs Holding TECH: 
87
Total Market Value Held by ETFs: 
$2.16B
Total Market Capitalization: 
$13.62B
% of Market Cap. Held by ETFs: 
15.84%
 

Open the TECH Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree TECH Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.33 out of 4)
34th percentile
(ranked lower than approx. 66% of all stocks covered)

Analysts' Target Price:
TECH Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Biotechnology M&A - Slide 58 of 83 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.